Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 1026706 in diabetic macular edema with mild visual impairment
2015-003529-33Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic macular edema (DME) comparing BI 1026706 with Placebo (2 arms). Primary endpoint: Change from baseline in central subfield thickness at week 12. Started Jan 2016; status: completed.
02
Drugs
BI 1026706
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on 2015-003529-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003529-33.